mortality/aging
• increased early mortality
|
cardiovascular system
• cerebral cavernous malformations develop as early as two months after tamoxifen treatment at 1 day of age
• most mice have lesions at 4 months and all mice at 6 months
• additional abnormalities include capillary telangiectasias, isolated caverns and multiple back to back caverns, thrombosis, hemorrhage, formation of secondary channels
• attenuation of endothelial cells in larger secondary channels but no gaps
|
• foot processes are missing
|
nervous system
• cerebral cavernous malformations develop as early as two months after tamoxifen treatment at 1 day of age
• most mice have lesions at 4 months and all mice at 6 months
• additional abnormalities include capillary telangiectasias, isolated caverns and multiple back to back caverns, thrombosis, hemorrhage, formation of secondary channels
• attenuation of endothelial cells in larger secondary channels but no gaps
|
• foci of mononuclear inflammatory cells also seen
|
• foot processes are missing
|
immune system
• foci of mononuclear inflammatory cells also seen
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
cerebral cavernous malformation 2 | DOID:0060670 |
OMIM:603284 |
J:173947 |